Back to LOOMIS SAYLES & CO L P LOOMIS SAYLES & CO L P

LGNDLGND
Showing 8 of 9 quarters

Position history for LOOMIS SAYLES & CO L PLOOMIS SAYLES & CO L P's holdings in LIGAND PHARMACEUTICALS INC

Yes. Loomis Sayles holds 291,805 shares of LGND (Ligand Pharmaceuticals), worth $92.2M, as of its Q2 2026 13F filing. It reduced the position by 61,404 shares (-17.4%) from Q1 2026. Loomis Sayles has held LGND since Q2 2024, across 9 quarterly 13F filings. LGND is 0.1% of Loomis Sayles' reported 13F portfolio.

Current Value

$92.2M

Current Shares

291,805

Total Value Change

+$54.9M

Total Shares Change

-80,974

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
291,805
-17.4%
$92.2M0.1%$316.09
0
2026-Q1
Decreased
353,209
-7.7%
$70.5M0.1%$199.65
0
2025-Q4
Decreased
382,677
-4.5%
$72.4M0.1%$189.07
0
2025-Q3
Decreased
400,553
-2.5%
$71M0.1%$177.14
0
2025-Q2
Decreased
410,897
-2.4%
$46.7M0.1%$113.68
0
2025-Q1
Increased
420,834
+5.8%
$44.2M0.1%$105.14
31
2024-Q4
Increased
397,700
+6.7%
$42.6M0.1%$107.15
31
2024-Q3
Increased
372,779
+44.3%
$37.3M0.0%$100.09
39

Other major holders of LGND: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used